Résultat de recherche

Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.

Annarita Miccio

Source :

Pmid / DOI:

An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype.

Annarita Miccio

Source :

Pmid / DOI:

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.

Annarita Miccio , Tristan Felix

Source :

Pmid / DOI:

Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications.

Annarita Miccio

Source :

Pmid / DOI:

Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.

Annarita Miccio

Source :

Pmid / DOI:

Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation.

Annarita Miccio

Source :

Pmid / DOI:

Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction of Human Embryonic Stem Cells.

Annarita Miccio

Source :

Pmid / DOI:

Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication.

Annarita Miccio

Source :

Pmid / DOI:

Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.

Annarita Miccio

Source :

Pmid / DOI:

Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts.

Annarita Miccio

Source :

Pmid / DOI:

The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene.

Annarita Miccio

Source :

Pmid / DOI: